Home › Funds › Champlain Investment Partners, LLC › CAI

Champlain Investment Partners, LLC position in CAI

CARIS LIFE SCIENCES INC · Health Care

Champlain Investment Partners, LLC reported holding 1,053,960 shares of CAI (CARIS LIFE SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$32.3M, representing 1.11% of its reported portfolio and ranking #21 among its reported holdings. Champlain Investment Partners, LLC has disclosed CAI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.05M sh
Reported value held$32.28M
Portfolio Weight1.11%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Champlain Investment Partners, LLC's CAI position evolved

Champlain Investment Partners, LLC first disclosed a stake in CAI in Q4 2025 at 939,365 shares (US$25.3M). The position peaked in Q3 2026 at 1,053,960 shares, worth US$32.3M. Across 4 filings, Champlain Investment Partners, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,053,960 shares valued at US$32.3M. Notable position changes include a 29% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 939.37K $25.34M New
Q1 2026 1.21M $21.60M Add
Q2 2026 1.05M $18.69M Reduce
Q3 2026 1.05M $32.28M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAI and 13F data

CAI (CARIS LIFE SCIENCES INC) is a Health Care company. 62 other funds we track also report a position in CAI — the largest reported positions include Coatue Management (US$175.0M), COATUE MANAGEMENT LLC (US$175.0M), BRAIDWELL LP (US$147.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAI

All CAI fund holders →

FAQ

How long has Champlain Investment Partners, LLC held CAI?

Champlain Investment Partners, LLC has disclosed CAI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Champlain Investment Partners, LLC's current position in CAI?

As of Q3 2026, Champlain Investment Partners, LLC holds 1.05M shares of CAI (CARIS LIFE SCIENCES INC), valued at $32.28M, representing 1.11% of its reported portfolio and ranking #21.

Has Champlain Investment Partners, LLC been buying or selling CAI?

In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC held unchanged its position in CAI. The position peaked in Q3 2026 at 1.05M shares.

Which other funds hold CAI?

Other major institutional holders of CAI include Coatue Management, COATUE MANAGEMENT LLC, BRAIDWELL LP, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.